BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25443154)

  • 1. Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic neoplasia.
    Carballo L; Enríquez-Navascués JM; Saralegui Y; Placer C; Timoteo A; Borda N; Carrillo A; Sainz-Lete A
    Cir Esp; 2015 Mar; 93(3):174-80. PubMed ID: 25443154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
    Kuhrt MP; Chokshi RJ; Arrese D; Martin EW
    World J Surg Oncol; 2012 Jun; 10():110. PubMed ID: 22703863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration with rectal resection for different types of malignancies at two tertiary referral centres.
    Garcia-Granero A; Biondo S; Espin-Basany E; González-Castillo A; Valverde S; Trenti L; Gil-Moreno A; Kreisler E
    Cir Esp (Engl Ed); 2018 Mar; 96(3):138-148. PubMed ID: 29229359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
    PelvExCollaborative
    Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pelvic exenteration--indications, radical nature and follow-up demonstrated with 33 clinical cases].
    Kolbert G; Müller G; Kujath P; Bruch HP
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1096-7. PubMed ID: 9574344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer.
    Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ
    Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layer-oriented total pelvic exenteration for locally advanced primary colorectal cancer.
    Koda K; Shuto K; Matsuo K; Kosugi C; Mori M; Hirano A; Hiroshima Y; Tanaka K
    Int J Colorectal Dis; 2016 Jan; 31(1):59-66. PubMed ID: 26255259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of advanced pelvic cancer by exenteration.
    Kecmanovic DM; Pavlov MJ; Kovacevic PA; Sepetkovski AV; Ceranic MS; Stamenkovic AB
    Eur J Surg Oncol; 2003 Nov; 29(9):743-6. PubMed ID: 14602493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
    Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
    Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of radical surgery for locally advanced pelvic neoplasia.
    Bramhall SR; Harrison JD; Burton A; Wallace DM; Chan KK; Harrison G; White A; Fielding JW
    Br J Surg; 1999 Jun; 86(6):805-12. PubMed ID: 10383583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic Exenteration for Locally Advanced and Relapsed Pelvic Malignancies - An Analysis of 100 Cases.
    Bacalbasa N; Balescu I; Vilcu M; Neacsu A; Dima S; Croitoru A; Brezean I
    In Vivo; 2019; 33(6):2205-2210. PubMed ID: 31662557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of pelvic exenteration for locally advanced primary or recurrent non-colorectal pelvic malignancies.
    Ueda T; Koyama F; Nakagawa T; Nakamura S; Nishigori N; Inoue T; Kawasaki K; Obara S; Nakamoto T; Fujii H; Nakajima Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2433-6. PubMed ID: 24394136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.